Update Report on Homotoxicology and Calciaum EDTA Chelation.
A Summary on 63 Patients Undergoing This Unique New Protocol;
Answering Questions on ‘What About Mercury?’
And Did You See the New England Journal Article on Jan 23rd 2003?

© Copyright 2003 by Bruce H Shelton M.D.M.D.(h) DiHOM & HEEL Inc USA Medical Director
(Explore Issue: Volume 12, Number 2)

ABSTRACT
We first published the start of this study in Volume 11 of Explore Magazine on Nov 6th 2002. This is an ongoing report on the 49 patients previously reported plus their total numbers are up to 63 as new patients have started the protocol.
The basic premise is that Calcium EDTA Chelation; itself a new innovation has been performed on these patients accompanied by a supplement program using Homotoxicology remedies manufactured by Heel and the results seem to show that more metals are excreted when Homotoxicology is added to the patient protocols.

Since the publication numerous questions have been received regarding other chelating agents such as DMPS/DMSA used for direct Mercury Chelation.

There was also an article in the Jan23rd 2003 issue of The New England Journal of Medicine with a study that showed CaEDTA Chelation used for Lead Exposure improved Renal Function, which is one of the first studies that showed the benefits of this newest chelating agent. Our Update report summarized herein continues to confirm that Homotoxicology optimizes the effects of CaEDTA Chelation.

The reader is directed to reread the First Article in the Nov 6th 2002 Issue of Explore, Volume 11, Number 6, in order to understand the rationale for this unique set of procedures.